|
KIAA1522 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.999400E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.679400E-03 |
| Normal-vs-Stage2 |
3.935400E-03 |
| Normal-vs-Stage3 |
5.567700E-04 |
| Normal-vs-Stage4 |
5.821600E-01 |
| Stage1-vs-Stage2 |
2.568000E-01 |
| Stage1-vs-Stage3 |
8.447700E-02 |
| Stage1-vs-Stage4 |
3.523200E-01 |
| Stage2-vs-Stage3 |
7.767000E-01 |
| Stage2-vs-Stage4 |
2.141400E-01 |
| Stage3-vs-Stage4 |
1.179620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.373400E-04 |
| Normal-vs-AfricanAmerican |
3.458300E-02 |
| Normal-vs-Asian |
1.016040E-01 |
| Caucasian-vs-AfricanAmerican |
1.046030E-01 |
| Caucasian-vs-Asian |
9.332000E-01 |
| AfricanAmerican-vs-Asian |
6.288000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.419200E-04 |
| Normal-vs-Female |
9.198300E-02 |
| Male-vs-Female |
2.564800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.500120E-02 |
| Normal-vs-Extreme_Weight |
1.039180E-03 |
| Normal-vs-Obese |
8.048300E-04 |
| Normal-vs-Extreme_Obese |
9.858000E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.020800E-01 |
| Normal_Weight-vs-Obese |
4.539000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.934000E-01 |
| Extreme_Weight-vs-Obese |
9.077600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.332400E-02 |
| Obese-vs-Extreme_Obese |
1.864420E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.856160E-01 |
| Normal-vs-Age(41-60Yrs) |
1.111780E-02 |
| Normal-vs-Age(61-80Yrs) |
1.376200E-04 |
| Normal-vs-Age(81-100Yrs) |
1.89160999999327E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.800200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.197200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.277710E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.974200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.537040E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.624000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.839450E-03 |
| Normal-VS-Type2 PRCC |
3.68100000003313E-06 |
| Normal-VS-KIRP CIMP |
9.871800E-01 |
| Normal-VS-Unclassified PRCC |
2.098000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.315030E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.701800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.837400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.924800E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
4.446300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.774010E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.162720E-04 |
| Normal-vs-N1 |
7.315900E-03 |
| Normal-vs-N2 |
8.700400E-01 |
| N0-vs-N1 |
6.543400E-01 |
| N0-vs-N2 |
3.363000E-01 |
| N1-vs-N2 |
1.707780E-01 |
|
|
